Does EPIRUBICIN Cause Myelosuppression? 934 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 934 reports of Myelosuppression have been filed in association with EPIRUBICIN (Ellence). This represents 5.7% of all adverse event reports for EPIRUBICIN.
934
Reports of Myelosuppression with EPIRUBICIN
5.7%
of all EPIRUBICIN reports
15
Deaths
497
Hospitalizations
How Dangerous Is Myelosuppression From EPIRUBICIN?
Of the 934 reports, 15 (1.6%) resulted in death, 497 (53.2%) required hospitalization, and 92 (9.9%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
Yes, Myelosuppression is listed as a known adverse reaction in the official FDA drug label for EPIRUBICIN.
What Other Side Effects Does EPIRUBICIN Cause?
Nausea (1,265)
Vomiting (978)
Neutropenia (926)
White blood cell count decreased (873)
Febrile neutropenia (809)
Diarrhoea (749)
Asthenia (732)
Pyrexia (729)
Fatigue (685)
Death (684)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which EPIRUBICIN Alternatives Have Lower Myelosuppression Risk?
EPIRUBICIN vs EPLERENONE
EPIRUBICIN vs EPLONTERSEN
EPIRUBICIN vs EPOETIN ALFA-EPBX
EPIRUBICIN vs EPOGEN
EPIRUBICIN vs EPOPROSTENOL